Early Life Represents a Vulnerable Time Window for IL-33–Induced Peripheral Lung Pathology
Li Y. Drake(Mayo Clinic), Hirohito Kita(Mayo Clinic), Takao Kobayashi(Hokkaido University), Diane L. Squillace(Mayo Clinic), Rodney D. Britt(Nationwide Children's Hospital), Daniel R. O’Brien(Mayo Clinic in Florida), Koji Iijima(WinnMed), Gail M. Kephart(Mayo Clinic), Masaru Uchida(Mayo Clinic)
Cited by 8
Related Papers
IL-33–Responsive Lineage−CD25+CD44hi Lymphoid Cells Mediate Innate Type 2 Immunity and Allergic Inflammation in the Lungs
|The Journal of Immunology|2011|552
The Danger Signal, Extracellular ATP, Is a Sensor for an Airborne Allergen and Triggers IL-33 Release and Innate Th2-Type Responses
|The Journal of Immunology|2011|490
IL-33–activated dendritic cells induce an atypical TH2-type response
|Journal of Allergy and Clinical Immunology|2009|400
Enhanced innate type 2 immune response in peripheral blood from patients with asthma
|Journal of Allergy and Clinical Immunology|2014|379
Proteases Induce Production of Thymic Stromal Lymphopoietin by Airway Epithelial Cells through Protease-Activated Receptor-2
|The Journal of Immunology|2009|358